These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1410791)
1. Bacteriocin-like activity of Bacteroides fragilis group isolated from marmosets. Farias LM; Carvalho MA; Damasceno CA; Cisalpino EO; Vieira EC Res Microbiol; 1992 Feb; 143(2):151-9. PubMed ID: 1410791 [TBL] [Abstract][Full Text] [Related]
2. Bacteriocin production by Actinobacillus actinomycetemcomitans isolated from the oral cavity of humans with periodontal disease, periodontally healthy subjects and marmosets. Lúcia LF; Farias FF; Eustáquio CJ; Auxiliadora M; Carvalho R; Alviano CS; Farias LM Res Microbiol; 2002; 153(1):45-52. PubMed ID: 11881898 [TBL] [Abstract][Full Text] [Related]
3. Bacteriocin production by Fusobacterium isolates recovered from the oral cavity of human subjects with and without periodontal disease and of marmosets. Oliveira AA; Farias LM; Nicoli JR; Costa JE; Carvalho MA Res Microbiol; 1998 Sep; 149(8):585-94. PubMed ID: 9795996 [TBL] [Abstract][Full Text] [Related]
4. Antagonism among Bacteroides fragilis group strains isolated from middle ear exudates from patients with chronic suppurative otitis media. Rocha ER; de Uzeda M Ear Nose Throat J; 1990 Sep; 69(9):614-8. PubMed ID: 2245788 [TBL] [Abstract][Full Text] [Related]
5. Production of bacteriocin by Bacteriodes fragilis and partial characterization. Avelar KE; Pinto LJ; Antunes LC; Lobo LA; Bastos MC; Domingues RM; Ferreira MC Lett Appl Microbiol; 1999 Oct; 29(4):264-8. PubMed ID: 10583756 [TBL] [Abstract][Full Text] [Related]
6. Extraction, partial purification and characterization of a bacteriocin (fragicilin) produced by a strain of Bacteroides fragilis isolated from Callithrix penicillata. Farias LM; Totola AH; Miranda CM; Carvalho MA; Damasceno CA; Tavares CA; Cisalpino EO; Vieira EC Res Microbiol; 1994 Jan; 145(1):9-16. PubMed ID: 8090990 [TBL] [Abstract][Full Text] [Related]
7. Isolation and identification of strains of Bacteroides fragilis group from the digestive tract of Callithrix penicillata marmosets. Avila-Campos MJ; Raymundo NL; Farias LM; Silva SL; Carvalho MA; Damasceno CA; Pereira LH; Cisalpino EO Lab Anim; 1990 Jan; 24(1):68-70. PubMed ID: 2106054 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets. Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091 [TBL] [Abstract][Full Text] [Related]
9. A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens. Ho PL; Ho LY; Yau CY; Tong MK; Chow KH J Clin Microbiol; 2017 Feb; 55(2):384-390. PubMed ID: 27852672 [TBL] [Abstract][Full Text] [Related]
10. Bacteroides fragilis: an exogenous pathogen? Domingues RM; De Oliveira M; Hirata Júnior R; De Andrade AF; Ferriera MC Zentralbl Bakteriol; 1995 Apr; 282(3):296-302. PubMed ID: 7549162 [TBL] [Abstract][Full Text] [Related]
11. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Mundy LM; Sears CL Clin Infect Dis; 1996 Aug; 23(2):269-76. PubMed ID: 8842262 [TBL] [Abstract][Full Text] [Related]
12. Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay. Pantosti A; Cerquetti M; Colangeli R; D'Ambrosio F J Med Microbiol; 1994 Sep; 41(3):191-6. PubMed ID: 8064839 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of cryptic plasmids in clinical isolates of Bacteroides fragilis. Beul HA; von Eichel-Streiber C; Schreiner M; Schwindling FP; Weinblum D; Zöllner EJ; Dierich M J Med Microbiol; 1985 Aug; 20(1):39-48. PubMed ID: 2991526 [TBL] [Abstract][Full Text] [Related]
14. News & notes: adhesiveness of Bacteroides fragilis strains isolated from feces of healthy donors, abscesses, and blood. Guzmàn CA; Biavasco F; Pruzzo C Curr Microbiol; 1997 May; 34(5):332-4. PubMed ID: 9099636 [TBL] [Abstract][Full Text] [Related]
15. [Bacteriocin formation and bacteriocin sensitivity in Bacterioides fragilis and Bacterioides thetaiotaomicron from clinical material]. Podhaisky C; Reinhold L Zentralbl Bakteriol Orig; 1970; 215(4):475-82. PubMed ID: 4925378 [No Abstract] [Full Text] [Related]
16. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance. Tierney D; Copsey SD; Morris T; Perry JD Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277 [TBL] [Abstract][Full Text] [Related]
17. Influence of abiotic factors on the bacteriocinogenic activity of Actinobacillus actinomycetemcomitans. Lima FL; Farias FF; Carvalho MA; Alviano CS; Farias LM Res Microbiol; 2002 May; 153(4):249-52. PubMed ID: 12066897 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Bandoh K; Ueno K; Watanabe K; Kato N Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152 [TBL] [Abstract][Full Text] [Related]
19. Gut Symbiont Chatzidaki-Livanis M; Coyne MJ; Roelofs KG; Gentyala RR; Caldwell JM; Comstock LE mBio; 2017 Nov; 8(6):. PubMed ID: 29184019 [TBL] [Abstract][Full Text] [Related]
20. Cross-inhibition between black-pigmented Bacteroides species. Van Winkelhoff AJ; Kippuw N; De Graaff J J Dent Res; 1987 Nov; 66(11):1663-7. PubMed ID: 10872403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]